Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.

Moteshafi H, Zhornitsky S, Brunelle S, Stip E.

Drug Saf. 2012 Oct 1;35(10):819-36. doi: 10.2165/11631510-000000000-00000.

PMID:
22967188
2.

Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.

Moteshafi H, Stip E.

Expert Opin Drug Saf. 2012 Sep;11(5):713-32. doi: 10.1517/14740338.2012.712682.

PMID:
22913713
3.

Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.

Stip E, Zhornitsky S, Moteshafi H, LĂ©tourneau G, Stikarovska I, Potvin S, Tourjman V.

Clin Ther. 2011 Dec;33(12):1853-67. doi: 10.1016/j.clinthera.2011.10.027. Epub 2011 Dec 1. Review.

PMID:
22133697
4.

Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.

Zhornitsky S, Potvin S, Moteshafi H, Dubreucq S, Rompré PP, Stip E.

Int Clin Psychopharmacol. 2011 Jul;26(4):183-92. doi: 10.1097/YIC.0b013e3283430a0e. Review.

PMID:
21372722

Supplemental Content

Loading ...
Write to the Help Desk